What term describes the prohibition against receiving two discounts on drugs?

The term that accurately describes the prohibition against receiving two discounts on drugs is "duplicate discount." In the context of the 340B Program, a duplicate discount occurs when a pharmaceutical company provides a discounted price for drugs under the 340B Program while a Medicaid claim is also made for the same drugs. This duplication is disallowed to prevent the excessive reduction of the drug price, which could compromise the financial integrity of both the 340B Program and Medicaid.

Ensuring that a provider does not receive two discounts for the same drug helps maintain the sustainability of the 340B Program and protects the interests of both the providers and the patients who rely on these services. The prohibition against duplicate discounts is critical for compliance and is a fundamental aspect of program operations. Therefore, recognizing this term is essential for anyone involved in 340B operations.